Tonix Pharmaceuticals Holding Corp.TNXPNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
6.99%
↑ 101% above average
Average (39q)
-654.95%
Historical baseline
Range
High:99.99%
Low:-15893.42%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 6.99% |
| Q2 2025 | -35.92% |
| Q1 2025 | 70.93% |
| Q4 2024 | -4147.83% |
| Q3 2024 | 99.99% |
| Q2 2024 | -234.72% |
| Q1 2024 | 90.68% |
| Q4 2023 | -15893.42% |
| Q3 2023 | 21.53% |
| Q2 2023 | 52.07% |
| Q1 2023 | 8.29% |
| Q4 2022 | 17.45% |
| Q3 2022 | 44.39% |
| Q2 2022 | 23.75% |
| Q1 2022 | 28.57% |
| Q4 2021 | 98.62% |
| Q3 2021 | -7090.67% |
| Q2 2021 | -0.45% |
| Q1 2021 | 30.00% |
| Q4 2020 | -11.11% |
| Q3 2020 | 60.87% |
| Q2 2020 | 37.84% |
| Q1 2020 | 71.77% |
| Q4 2019 | 73.67% |
| Q3 2019 | 45.99% |
| Q2 2019 | 10.09% |
| Q1 2019 | 69.78% |
| Q4 2018 | 36.61% |
| Q3 2018 | 26.87% |
| Q2 2018 | 18.98% |
| Q1 2018 | -26.25% |
| Q4 2017 | 12.98% |
| Q3 2017 | -21.05% |
| Q2 2017 | 48.51% |
| Q1 2017 | 32.32% |
| Q4 2016 | 34.18% |
| Q3 2016 | 42.04% |
| Q2 2016 | 53.22% |
| Q1 2016 | -4.61% |
| Q4 2015 | -0.83% |